CYBERDYNE Online Store

🔍

PRESS RELEASES BACK NUMBER

SEARCH
2021-11-08
【IR News】Notice regarding the acquisition of RISE, a U.S. Rehabilitation Medical Institution
2021-11-01
【News】Announcement on adoption by JICA project
2021-10-05
【IR News】Announce on the adoption by AMED Medical Engineering Innovation Promotion Project ~ enables real-time photoacoustic imaging of peripheral capillaries and oxygenation level distribution~
2021-09-21
【News】CYBERDYNE formed a capital and business alliance with GAIA BioMedicine, a company that develops cancer immunotherapy
2021-09-13
【News】CYBERDYNE formed a capital and business alliance with Adriakaim, a company that develops a vagus nerve stimulation device
2021-09-07
【News】CL02 was adopted by Kanagawa prefecture for their Robot Implementation Project ~Verification of CL02 for deployment in medical facility~
2021-09-06
【IR News】Announcement on large orders for HAL Lumbar Type
~ Signed a long-term contract with Hampshire County Council in the UK ~
2021-09-03
【News】CYBERDYNE signs strategic partnership agreement with MIE Racing
2021-09-02
【News】Medical HAL Single Joint Type receives medical device approval from Australian regulator
2021-08-31
【IR News】Notice regarding the acquisition of C2, developer of smartphone app “JUKUSUI”
2021-08-30
【News】CYBERDYNE listed Medical HAL Single Joint Type to U.S. FDA as Class I Medical Device
2021-08-26
【News】Notice of application for the additional indication of Medical HAL for Spastic Paraplegia including HTLV-1 Associated Myelopathy (HAM)
2021-08-12
【News】Medical HAL introduced to one of the largest hospital in France
2021-08-11
【News】Medical HAL installed to largest hospital in the Basque region, Spain
2021-08-05
【News】Formed a capital and business alliance with KanonCure, a company that develops cell sheets for the treatment of liver diseases
2021-07-30
【News】Business alliance with J-Workout, the largest gym specializing in spinal cord injury
2021-07-26
【News】Details report of the investigator-initiated clinical trial of Medical HAL for neuromuscular disease patients published in an international medical journal
2021-07-15
【News】CYBERDYNE joins Nippon Keidanren
2021-06-23
【News】Preliminary results of Medical HAL Lower Limb Type stroke clinical trial
2021-06-04
【News】 HAL at Home, 29,800-yen trial campaign for the first month
~ Supports functional recovery from disease/injuries and prevents frailty in the elderly~
BACK TO TOP

© 2025 CYBERDYNE INC. ALL RIGHTS RESERVED.